Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data.

Jun Sik YoonByeong Geun SongJeong-Hoon LeeHyo Young LeeSun Woong KimYoung ChangYun Bin LeeEun Ju ChoSu Jong YuDong Hyun SinnYoon Jun KimJoon Hyeok LeeJung-Hwan Yoon

Published in: BMC cancer (2019)

The adjuvant immunotherapy with autologous CIK cells after curative treatment safely prolonged the RFS of HCC patients in a real-world setting.

Keyphrases

early stage
end stage renal disease
prognostic factors
ejection fraction
induced apoptosis
cell therapy
newly diagnosed
single cell
bone marrow
peritoneal dialysis
cell cycle arrest
big data
signaling pathway
platelet rich plasma
rectal cancer
patient reported outcomes
replacement therapy